BR0306038A - Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas - Google Patents

Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas

Info

Publication number
BR0306038A
BR0306038A BR0306038-1A BR0306038A BR0306038A BR 0306038 A BR0306038 A BR 0306038A BR 0306038 A BR0306038 A BR 0306038A BR 0306038 A BR0306038 A BR 0306038A
Authority
BR
Brazil
Prior art keywords
oligonucleotide probes
albumin protein
conjugated oligonucleotide
protein conjugated
oligonucleotide
Prior art date
Application number
BR0306038-1A
Other languages
English (en)
Inventor
H Ben Hsieh
Original Assignee
Palo Alto Res Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palo Alto Res Ct Inc filed Critical Palo Alto Res Ct Inc
Publication of BR0306038A publication Critical patent/BR0306038A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PROCESSO PARA PREPARAR SONDAS DE OLIGONUCLEOTìDEOS CONJUGADOS COM PROTEìNAS DE ALBUMINAS". A presente invenção refere-se a uma técnica para formar conjugados de proteínas e oligonucleotídeos, cuja conjugação é realizada enquanto o oligonucleotídeo está afixado ao meio de suporte, tais como pérolas de vidro. O produto conjugado pode ser então facilmente removido do meio de suporte. Descreve-se também os produtos conjugados formados por esta técnica. A presente invenção é particularmente direcionada para conjugados de proteínas de albumina, e especificamente, albumina sérica bovina (BSA).
BR0306038-1A 2002-12-18 2003-12-17 Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas BR0306038A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/323,385 US6913890B2 (en) 2002-12-18 2002-12-18 Process for preparing albumin protein conjugated oligonucleotide probes

Publications (1)

Publication Number Publication Date
BR0306038A true BR0306038A (pt) 2004-08-17

Family

ID=32593199

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0306038-1A BR0306038A (pt) 2002-12-18 2003-12-17 Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas

Country Status (2)

Country Link
US (2) US6913890B2 (pt)
BR (1) BR0306038A (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US20040010134A1 (en) * 2000-04-12 2004-01-15 Rosen Craig A. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
DK1463751T3 (da) 2001-12-21 2013-08-26 Human Genome Sciences Inc Albuminfusionsproteiner.
US7906630B2 (en) * 2004-04-27 2011-03-15 PerkinElmer Heath Sciences, Inc. Method for identifying peptides in a biological sample
CN102181550B (zh) * 2011-04-18 2014-07-09 深圳康美生物科技股份有限公司 一种检测多种病原微生物的方法和试剂盒
DK2972353T3 (da) * 2013-03-11 2023-03-27 Meso Scale Technologies Llc Forbedrede fremgangsmåder til udførelse af multipleksanalyser
US10478503B2 (en) 2016-01-31 2019-11-19 University Of Massachusetts Branched oligonucleotides
WO2018031933A2 (en) 2016-08-12 2018-02-15 University Of Massachusetts Conjugated oligonucleotides
MX2021001590A (es) 2018-08-10 2021-07-02 Univ Massachusetts Oligonucleótidos modificados dirigidos a snp.
US11492619B2 (en) 2019-01-18 2022-11-08 University Of Massachusetts Dynamic pharmacokinetic-modifying anchors
WO2022271786A1 (en) 2021-06-23 2022-12-29 University Of Massachusetts Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935494A (en) * 1988-11-15 1990-06-19 City Of Hope C-terminal peptide and protein sequencing
US5578718A (en) * 1990-01-11 1996-11-26 Isis Pharmaceuticals, Inc. Thiol-derivatized nucleosides
EP0537299A1 (en) 1990-03-29 1993-04-21 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5218105A (en) * 1990-07-27 1993-06-08 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
EP1331011A3 (en) 1991-10-24 2003-12-17 Isis Pharmaceuticals, Inc. Derivatized oligonucleotides having improved uptake and other properties
US5767238A (en) * 1995-06-07 1998-06-16 Combichem, Inc. Inverse solid phase synthesis
EP0844252A3 (en) * 1996-11-15 1998-07-08 Remacle, José Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
US5837466A (en) * 1996-12-16 1998-11-17 Vysis, Inc. Devices and methods for detecting nucleic acid analytes in samples
US5977299A (en) * 1997-04-07 1999-11-02 Dade Behring Marburg Gmbh Activated peptides and conjugates
AU741546B2 (en) 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
US6210908B1 (en) * 1998-11-11 2001-04-03 Dade Behring Marburg Gmbh Activated peptides and conjugates
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
US6656730B1 (en) * 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6911535B2 (en) * 2000-03-22 2005-06-28 Solvlink Biosciences Biomolecule/polymer conjugates
US20020068818A1 (en) * 2000-08-09 2002-06-06 Vince Pozsgay Conjugation of biomolecules using diels-alder cycloaddition
US6673905B2 (en) * 2000-08-09 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Conjugation of biomolecules using Diels-Alder cycloaddition
US6559279B1 (en) 2000-09-08 2003-05-06 Isis Pharmaceuticals, Inc. Process for preparing peptide derivatized oligomeric compounds
US20040038331A1 (en) * 2002-08-23 2004-02-26 Reddy M. Parameswara Solid phase synthesis of biomolecule conjugates

Also Published As

Publication number Publication date
US20050244884A1 (en) 2005-11-03
US20040121426A1 (en) 2004-06-24
US7538192B2 (en) 2009-05-26
US6913890B2 (en) 2005-07-05

Similar Documents

Publication Publication Date Title
BR0306038A (pt) Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas
TW200612989A (en) Process for concentration of antibodies and therapeutic products thereof
BR0114475A (pt) Célula para a produção de composição de anticorpo
ATE495436T1 (de) Verfahren zur isolierung und markierung von probenmolekülen
WO2000054046A3 (en) Universal protein array system
BR9913360A (pt) Oxidase de urato
DE60034566D1 (de) Peptidakzeptor ligationsverfahren
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
BRPI0519172A2 (pt) proteÍna mutante, polinucleotÍdeo, microorganismo transformado, e, mÉtodos de produzir uma proteÍna mutante, um peptÍdeo, e alfa-l-aspartil-l-fenilalanina-beta-Éster, e de projetar e produzir uma proteÍna mutante
Wu et al. Sortase-mediated transpeptidation for site-specific modification of peptides, glycopeptides, and proteins
BR112018003594A2 (pt) cadeia pesada de imunoglobulina recombinante, anticorpos, método de produção de conjugado e conjugados
BR1100315A (pt) Processo para melhorar a imunogenicidade de um imunogênio ou de um hapteno, gene de fusão, vetor de dna, medicamento e utilização de um complexo entre um imunogênio e uma mólecula
DE60236361D1 (de) Sortierungs und immobilisationssystem für nukleins
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
Singh et al. Nonenzymatic rubylation and ubiquitination of proteins for structural and functional studies
NO20030495L (no) Peptider som presenteres av celler
CA2101734A1 (en) Compounds and conjugates
BR0008766A (pt) Sistema de vetor de rna de componente múltiplo para expressão de sequências estranhas
BR0015287A (pt) Moléculas recombinantes de fusão
DE602006011301D1 (de) Stützplatte für kosmetikprodukte
Belov et al. How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP
BR9811542A (pt) Identificação de linhas de células humanas para a produção de proteìnas humanas mediante ativação de genes endógena
WO2001066709A3 (en) Sphingomyelinase enzymes and uses relating thereto
Hua et al. Heterobifunctional Cross-Linker with Dinitroimidazole and N-Hydroxysuccinimide Ester Motifs for Protein Functionalization and Cysteine–Lysine Peptide Stapling
BR0113623A (pt) Proteìnas sintéticas de estìmulo da eritropoiese

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]